Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway

Gene

Volumn 298, Issue 1, 2002, Pages 9-19

  Andrew, Scott D ^a,b   Capes Davis, Amanda ^a   Delhanty, Patric J D ^a   Marsh, Deborah J ^a   Mulligan, Lois M ^b   Robinson, Bruce G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Early growth response gene 1; Medullary thyroid carcinoma; Sephacryl and phosphocellulose protein 1

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN RET; SEPHACRYL AND PHOSPHOCELLULOSE PROTEIN 1; TRANSCRIPTION FACTOR EGR 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NERVE FIBER GROWTH; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTO ONCOGENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL SIZE; DNA-BINDING PROTEINS; DOWN-REGULATION; DROSOPHILA PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; IMMEDIATE-EARLY PROTEINS; LUCIFERASES; MAP KINASE SIGNALING SYSTEM; NUCLEAR PROTEINS; OLIGONUCLEOTIDES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; RESPONSE ELEMENTS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0037130936     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(02)00919-8     Document Type: Article

References (37)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
2. Andrew S.D., Delhanty P.J., Mulligan L.M., Robinson B.G. Sp1 and Sp3 transactivate the RET proto-oncogene promoter. Gene. 256:2000;283-291.
3. Apt D., Watts Robin M., Suske G., Bernard H.-U. High Sp1/Sp3 rations in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology. 224:1996;281-291.
4. Bahouth S.W., Beauchamp M.J., Vu K.N. Reciprocal regulation of beta(1)-adrenergic receptor gene transcription by Sp1 and early growth response gene 1: induction of EGR-1 inhibits the expression of the beta(1)-adrenergic receptor gene. Mol. Pharmacol. 61:2002;379-390.
5. Califano D., Rizzo C., D'Alessio A., Colucci-D'Amato G.L., Cali G., Bartoli P.C., Santelli G., Vecchio G., de Franciscis V. Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells. J. Biol. Chem. 275:2000;19297-19305.
6. Calogero A., Arcella A., De Gregorio G., Porcellini A., Mercola D., Liu C., Lombari V., Zani M., Giannini G., Gagliardi F.M., Caruso R., Gulino A., Frati L., Ragona G. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin. Cancer Res. 7:2001;2788-2796.
7. Cao X.M., Mahendran R., Guy G.R., Tan Y.H. Detection and characterisation of cellular Egr-1 binding to its recognition site. J. Biol. Chem. 268:1993;16949-16957.
8. Carson E.B., McMahon M., Baylin S.B., Nelkin B.D. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation. Cancer Res. 55:1995;2048-2052.
9. Carsonwalter E.B., Smith D.P., Ponder B.A.J., Baylin S.B., Nelkin B.D. Post-transcriptional silencing of Ret occurs, but is not required, during Raf-1 mediated differentiation of medullary thyroid carcinoma cells. Oncogene. 17:1998;367-376.
10. de Belle I., Huang R.P., Fan Y., Liu C., Mercola D., Adamson E.D. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene. 18:1999;3633-3642.
11. deBustros A., Baylin S.B., Levine M.A., Nelkin B.D. Cyclic AMP and phorbol esters separately induce growth inhibition, calcitonin secretion, and calcitonin gene transcription in cultured human medullary thyroid carcinoma. J. Biol. Chem. 261:1986;8036-8041.
12. Delhanty P.J., Scott C.D., Babu S., Baxter R.C. Acid-labile subunit regulation during the early stages of liver regeneration: implications for glucoregulation. Am. J. Physiol. Endocrinol. Metab. 280:2001;E287-E295.
13. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
14. Fanton C.P., McMahon M., Pieper R.O. Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation. J. Biol. Chem. 276:2001;18871-18877.
15. Gashler A.L., Swaminathan S., Sukhatme V.P. A novel repression module, an extensive activation domain, and a bipartite nuclear localisation signal defined in the immediate-early transcription factor Egr-1. Mol. Cell. Biol. 13:1993;4556-4571.
16. Hansford J.R., Mulligan L.M. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J. Med. Genet. 37:2000;817-827.
17. Holler M., Westin G., Jiricny J., Schaffner W. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev. 2:1988;1127-1135.
18. Huang R.P., Liu C.T., Fan Y., Mercola D., Adamson E.D. Egr-1 negatively regulates human tumor cell growth via the Dna-binding domain. Cancer Res. 55:1995;5054-5062.
19. Huang R.P., Fan Y., Debelle I., Niemeyer C., Gottardis M.M., Mercola D., Adamson E.D. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int. J. Cancer. 72:1997;102-109.
20. Itoh F., Ishizaka Y., Tahira T., Yamamoto M., Miya A., Imai K., Yachi A., Takai S., Sugimura T., Nagao M. Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2 A patients. Oncogene. 7:1992;1201-1206.
21. Jackson S.P., MacDonald J.J., Lees-Miller S., Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell. 63:1990;155-165.
22. Leong S.S., Horaszewicz J.S., Shimaoka K., Friedman M., Kawinski E., Song M.J., Zeigel R., Chu T.M., Baylin S.B., Mirand E.A. A new cell line for study of human medullary thyroid. Andreoli M., Monaco F., Robbins J., Advances in Thyroid Neoplasia. 1981;95-108 Educational Italia, Rome.
23. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:1998;3008-3019.
24. McMahon A.P., Champion J.E., McMahon J.A., Sukhatme V.P. Developmental expression of the putative transcription factor Egr-1 suggests that Egr-1 and c-fos are coregulated in some tissues. Development. 108:1990;281-287.
25. Munnes M., Patrone G., Schmitz B., Romeo G., Doerfler W. A 5′-CG-3′-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residues. Oncogene. 17:1998;2573-2583.
26. Nakagawa T., Mabry M., de Bustros A., Ihle J.N., Nelkin B.D., Baylin S.B. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc. Natl. Acad. Sci. USA. 84:1987;5923-5927.
27. Pachnis V., Mankoo B., Costantini F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development. 119:1993;1005-1017.
28. Saarma M., Sariola H. Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF). Microsc. Res. Tech. 45:1999;292-302.
29. Santiago F.S., Lowe H.C., Day F.L., Chesterman C.N., Khachigian L.M. Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am. J. Pathol. 154:1999;937-944.
30. Santoro M., Rosati R., Grieco M., Berlingieri M.T., D'Amato G.L., de Franciscis V., Fusco A. The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene. 5:1990;1595-1598.
31. Silverman E.S., Du J., Williams A.J., Wadgaonkar R., Drazen J.M., Collins T. cAMP-response-element-binding-protein-binding protein (CBP) and p300 are transcriptional co-activators of early growth response factor-1 (Egr-1). Biochem. J. 336:(Pt 1):1998;183-189.
32. Skerka C., Decker E.L., Zipfel P.F. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem. 270:1995;22500-22506.
33. Srivastava S., Weitzmann M.N., Kimble Robert B., Rizzo M., Zahner M., Milbrandt J., Ross F.P., Pacifici R. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J. Clin. Invest. 102:1998;1850-1859.
34. Sukhatme V.P., Cao X.M., Chang L.C., Tsai-Morris C.H., Stamenkovich D., Ferreira P.C., Cohen D.R., Edwards S.A., Shows T.B., Curran T., et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarisation. Cell. 53:1988;37-43.
35. Takaya K., Yoshimasa T., Arai H., Tamura N., Miyamoto Y., Itoh H., Nakao K. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin. J. Mol. Med. 74:1996;617-621.
36. Turner J., Crossley M. Mammalian Kruppel-like transcription factors: more than just a pretty finger. Trends Biochem. Sci. 24:1999;236-240.
37. Zhang T., Wolfe M.W., Roberson M.S. An early growth response protein (Egr) 1 cis-element is required for gonadotropin-releasing hormone-induced mitogen-activated protein kinase phosphatase 2 gene expression. J. Biol. Chem. 276:2001;45604-45613.